Content specific to this active ingredient… Drug Information Prescribing and patient information from leading authorities Drug Master Files Type 2 master files on file at the FDA Drug Recalls For prescription drugs containing this active ingredient Exclusivity Patent and market exclusivity data Federal Register FR search results for this API FDA Approved Labelling Information found in this drug's package inserts Research Links Chemical identification and research citations Title 21 Code of Federal Regulations FDA regulations for this API

FDA Approval Activities for this Drug… Kaletra (lopinavir) oral solution, lopinavir/ ritonavir.Patient Package Insert. Abbott 21-251 9/15/00 9/18/00 9/18/00 3/26/02 Kaletra Indication:Kaletra is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infections in adults and pediatric patients age six months and older. Kaletra (lopinavir/ritonavir) Abbott 21-226/S6 & 21-251/S5 11/27/02 12/4/02 Kaletra (lopinavir/ritonavir) Abbott 21-226/S3 & 21-251/S4 1/18/02 2/5/02 2/5/02 3/26/02 Kaletra (lopinavir/ritonavir) Capsules & Solution, 133.3/33. Capsules and 80/ Solution., Abbott 21-226/S2 & 21-251/S2 3/13/01 4/25/01 3/26/02 3/26/02 Kaletra (lopinavir) 133. lopinavir/33. ritonavir. Patient Package Insert Abbott 21-226 9/15/00 9/18/00 9/18/00 3/26/02 Kaletra Indication: Kaletra is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infections in adults and pediatric patients age six months and older. Kaletra (lopinavir/ritonavir) Abbott Laboratories | KALETRA (lopinavir/ritonavir) capsules, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) oral solution, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) capsules, Abbott Labs, New Dosage Regimen | KALETRA (lopinavir/ritonavir) tablets, Abbott Labs, Approval | KALETRA (lopinavir/ritonavir) tablet, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) oral solution, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) capsules, Abbott Labs, Labeling Revision | Kaletra (lopinavir/ritonavir) Oral Solution, Abbott Labs, Labeling Revision | Kaletra (lopinavir/ritonavir) Tablets, Abbott Labs, Labeling Revision | KALETRA (Lopinavir/ Ritonavir) Oral, Abbott Labs, Efficacy Supp. w/Clinical Data | KALETRA (Lopinavir/Ritonavir) Tablets, Abbott Labs, Efficacy Supp. w/Clinical Data | Kaletra (lopinavir/ritonavir) Oral Solution, Abbott Labs, Labeling Revision | Kaletra (lopinavir/ ritonavir) Tablets, Abbott Labs, Labeling Revision | Kaletra (lopinavir/ritonavir) Capsules, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) Capsules, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) Tablets, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) Oral Solution, Abbott Labs, Labeling Revision | KALETRA (lopinavir/ritonavir) Oral Solution, Abbott Labs, New Dosage Regimen | KALETRA (lopinavir/ritonavir) Tablets, Abbott Labs, New Dosage Regimen | KALETRA (lopinavir and ritonavir) Oral Solution, Abbott Laboratories, Patient Population Altered | KALETRA (lopinavir and ritonavir) Tablets, Abbott Laboratories, Labeling Revision | Kaletra (lopinavir and ritonavir) Oral Solution, Abbott Laboratories, Labeling Revision | Kaletra (lopinavir and ritonavir) Oral Solution, Abbott Laboratories, Labeling Revision | Kaletra (lopinavir and ritonavir) Tablets, Abbott Laboratories, Labeling Revision ^ FDA's latest approval appears at the bottom of this list. ^   A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U-Z Health Topics | News Feed for each API | DMF Index | Pharma Job Search | Pharma Company News © 2008 Betterchem.com